Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Next Generation Diabetes Therapy and Drug Delivery market report explains the definition, types, applications, major countries, and major players of the Next Generation Diabetes Therapy and Drug Delivery market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Abbott Laboratories
MannKind Corporation
Senseonics
Eli Lilly and Company
Zosano Pharma
Medtronic
Enteris BioPharma
Sanofi
Medtech
Johnson & Johnson
Novo Nordisk
Transdermal Specialties
Dexcom
Relmada Therapeutics
Synertech
By Type:
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
By End-User:
Diagnostic/Clinics
ICUs
Home Healthcare
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Next Generation Diabetes Therapy and Drug Delivery Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Next Generation Diabetes Therapy and Drug Delivery Outlook to 2028- Original Forecasts
-
2.2 Next Generation Diabetes Therapy and Drug Delivery Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Next Generation Diabetes Therapy and Drug Delivery Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Next Generation Diabetes Therapy and Drug Delivery Market- Recent Developments
-
6.1 Next Generation Diabetes Therapy and Drug Delivery Market News and Developments
-
6.2 Next Generation Diabetes Therapy and Drug Delivery Market Deals Landscape
7 Next Generation Diabetes Therapy and Drug Delivery Raw Materials and Cost Structure Analysis
-
7.1 Next Generation Diabetes Therapy and Drug Delivery Key Raw Materials
-
7.2 Next Generation Diabetes Therapy and Drug Delivery Price Trend of Key Raw Materials
-
7.3 Next Generation Diabetes Therapy and Drug Delivery Key Suppliers of Raw Materials
-
7.4 Next Generation Diabetes Therapy and Drug Delivery Market Concentration Rate of Raw Materials
-
7.5 Next Generation Diabetes Therapy and Drug Delivery Cost Structure Analysis
-
7.5.1 Next Generation Diabetes Therapy and Drug Delivery Raw Materials Analysis
-
7.5.2 Next Generation Diabetes Therapy and Drug Delivery Labor Cost Analysis
-
7.5.3 Next Generation Diabetes Therapy and Drug Delivery Manufacturing Expenses Analysis
8 Global Next Generation Diabetes Therapy and Drug Delivery Import and Export Analysis (Top 10 Countries)
-
8.1 Global Next Generation Diabetes Therapy and Drug Delivery Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Next Generation Diabetes Therapy and Drug Delivery Export by Region (Top 10 Countries) (2017-2028)
9 Global Next Generation Diabetes Therapy and Drug Delivery Market Outlook by Types and Applications to 2022
-
9.1 Global Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Inhalable Insulin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Insulin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Insulin Patches Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CGM Systems Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Artificial Pancreas Consumption and Growth Rate (2017-2022)
-
9.2 Global Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostic/Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ICUs Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Healthcare Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Next Generation Diabetes Therapy and Drug Delivery Market Analysis and Outlook till 2022
-
10.1 Global Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.2.2 Canada Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.2.3 Mexico Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.2 UK Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.3 Spain Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.4 Belgium Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.5 France Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.6 Italy Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.7 Denmark Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.8 Finland Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.9 Norway Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.10 Sweden Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.11 Poland Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.12 Russia Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.3.13 Turkey Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.2 Japan Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.3 India Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.4 South Korea Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.5 Pakistan Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.6 Bangladesh Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.7 Indonesia Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.8 Thailand Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.9 Singapore Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.10 Malaysia Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.11 Philippines Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.4.12 Vietnam Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.5.2 Colombia Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.5.3 Chile Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.5.4 Argentina Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.5.5 Venezuela Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.5.6 Peru Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.5.7 Puerto Rico Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.5.8 Ecuador Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.6.2 Kuwait Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.6.3 Oman Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.6.4 Qatar Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.6.5 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.6.6 United Arab Emirates Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.7.2 South Africa Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.7.3 Egypt Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.7.4 Algeria Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
10.8.2 New Zealand Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
11 Global Next Generation Diabetes Therapy and Drug Delivery Competitive Analysis
-
11.1 Abbott Laboratories
-
11.1.1 Abbott Laboratories Company Details
-
11.1.2 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.1.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 MannKind Corporation
-
11.2.1 MannKind Corporation Company Details
-
11.2.2 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.2.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Senseonics
-
11.3.1 Senseonics Company Details
-
11.3.2 Senseonics Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.3.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eli Lilly and Company
-
11.4.1 Eli Lilly and Company Company Details
-
11.4.2 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.4.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Zosano Pharma
-
11.5.1 Zosano Pharma Company Details
-
11.5.2 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.5.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Medtronic
-
11.6.1 Medtronic Company Details
-
11.6.2 Medtronic Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.6.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Enteris BioPharma
-
11.7.1 Enteris BioPharma Company Details
-
11.7.2 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.7.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Sanofi
-
11.8.1 Sanofi Company Details
-
11.8.2 Sanofi Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.8.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Medtech
-
11.9.1 Medtech Company Details
-
11.9.2 Medtech Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.9.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Johnson & Johnson
-
11.10.1 Johnson & Johnson Company Details
-
11.10.2 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.10.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novo Nordisk
-
11.11.1 Novo Nordisk Company Details
-
11.11.2 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.11.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Transdermal Specialties
-
11.12.1 Transdermal Specialties Company Details
-
11.12.2 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.12.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Dexcom
-
11.13.1 Dexcom Company Details
-
11.13.2 Dexcom Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.13.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Relmada Therapeutics
-
11.14.1 Relmada Therapeutics Company Details
-
11.14.2 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.14.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Synertech
-
11.15.1 Synertech Company Details
-
11.15.2 Synertech Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
11.15.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
11.15.5 Recent Research and Development Strategies
12 Global Next Generation Diabetes Therapy and Drug Delivery Market Outlook by Types and Applications to 2028
-
12.1 Global Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Inhalable Insulin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Oral Insulin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Insulin Patches Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global CGM Systems Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Artificial Pancreas Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Diagnostic/Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global ICUs Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Home Healthcare Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Next Generation Diabetes Therapy and Drug Delivery Market Analysis and Outlook to 2028
-
13.1 Global Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.2.2 Canada Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.2.3 Mexico Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.2 UK Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.3 Spain Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.4 Belgium Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.5 France Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.6 Italy Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.7 Denmark Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.8 Finland Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.9 Norway Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.10 Sweden Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.11 Poland Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.12 Russia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.3.13 Turkey Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.2 Japan Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.3 India Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.4 South Korea Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.8 Thailand Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.9 Singapore Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.11 Philippines Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.5.2 Colombia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.5.3 Chile Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.5.4 Argentina Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.5.6 Peru Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.6.3 Oman Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.6.4 Qatar Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.7.2 South Africa Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.7.3 Egypt Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.7.4 Algeria Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Next Generation Diabetes Therapy and Drug Delivery
-
Figure of Next Generation Diabetes Therapy and Drug Delivery Picture
-
Table Global Next Generation Diabetes Therapy and Drug Delivery Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Next Generation Diabetes Therapy and Drug Delivery Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Inhalable Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Patches Consumption and Growth Rate (2017-2022)
-
Figure Global CGM Systems Consumption and Growth Rate (2017-2022)
-
Figure Global Artificial Pancreas Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic/Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global ICUs Consumption and Growth Rate (2017-2022)
-
Figure Global Home Healthcare Consumption and Growth Rate (2017-2022)
-
Figure Global Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Table North America Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Figure United States Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Canada Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Mexico Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Europe Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Figure Germany Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure UK Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Spain Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Belgium Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure France Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Italy Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Denmark Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Finland Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Norway Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Sweden Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Poland Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Russia Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Turkey Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table APAC Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Figure China Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure India Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure South Korea Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Thailand Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Singapore Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Philippines Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table South America Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Figure Brazil Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Colombia Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Chile Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Argentina Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Peru Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table GCC Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Figure Bahrain Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Oman Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Qatar Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Africa Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Figure Nigeria Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure South Africa Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Egypt Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Algeria Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Oceania Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Figure Australia Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table MannKind Corporation Company Details
-
Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Senseonics Company Details
-
Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Zosano Pharma Company Details
-
Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Medtronic Company Details
-
Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Enteris BioPharma Company Details
-
Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Medtech Company Details
-
Table Medtech Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtech Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Medtech Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Transdermal Specialties Company Details
-
Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Dexcom Company Details
-
Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Relmada Therapeutics Company Details
-
Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Table Synertech Company Details
-
Table Synertech Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synertech Next Generation Diabetes Therapy and Drug Delivery Main Business and Markets Served
-
Table Synertech Next Generation Diabetes Therapy and Drug Delivery Product Portfolio
-
Figure Global Inhalable Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Patches Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CGM Systems Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Artificial Pancreas Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic/Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ICUs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Healthcare Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Table North America Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure United States Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Germany Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure China Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Brazil Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Australia Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
